Tom Keith-Roach, president of AstraZeneca UK, said on Wednesday that they are scaling up to release over 2 million doses of their coronavirus vaccine in the UK very shortly, as reported by Reuters.
“Production of vaccine is 3-4 month process.”
“We can give high visibility on supply timetable through to the end of Q1 this year.”
“Hope to be 2 million doses a week on or before mid-February.”
“Process optimisation may make more than 2 million doses a week for UK possible, but can’t commit to that.”
“COVID outbreaks are hindering vaccine development workforce.”
“We have requested that vaccine developers and trial staff are prioritised for receiving a shot.”
The UK’s FTSE pared its earlier losses after these remarks and was last seen posting small gains at 6,756.